This inventor holds 1 USPTO granted patent. Top assignee: Il-Yang Pharm. Co., Ltd. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Woo-Chul Bae: Innovator in Cancer Treatment
Introduction
Woo-Chul Bae is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various types of cancer. His innovative work has the potential to impact the lives of many patients suffering from serious illnesses.
Latest Patents
Woo-Chul Bae holds a patent for N-phenyl-2-pyrimidine-amine derivatives and the process for their preparation. This invention relates to a compound that demonstrates superior effects against multiple forms of cancer, including lung cancer, gastric cancer, colon cancer, and more. The patent also covers a pharmaceutical composition that includes an effective amount of the compound as an active ingredient, combined with pharmaceutically acceptable inert carriers.
Career Highlights
Bae is associated with Il-yang Pharm. Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has led to advancements that could change the landscape of cancer treatment.
Collaborations
Some of his notable coworkers include Dong-Yeon Kim and Jae-Gun Kim, who have collaborated with him on various projects within the company.
Conclusion
Woo-Chul Bae's contributions to cancer treatment through his patented inventions highlight the importance of innovation in the pharmaceutical field. His work not only showcases his expertise but also offers hope for improved therapies for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile